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NIEHS News
Genetic Susceptibility
The simultaneous study of environmental
and genetic factors has become practical
with recent advances
in techniques for
measuring muta-
tions or polymor-
phisms in DNA.
One ofthe most im-
portant public health
applications of mol-
ecular genetics, and
of the Human Gen-
ome Project, is the Dr. Jack A. Taylor
description ofgenes that may affect suscep-
tibility to disease. NIEHS is using basic
genetic research to improve the ability to
detect environmental toxins.
NIEHS is collaborating with the
Environmental Protection Agency and the
National Center for Health Statistics to
identify and test candidate susceptibility
genes. Epidemiologic case-control studies
allow the simultaneous examination of
polymorphic genes, environmental expo-
sures, and gene-gene and gene-environ-
ment interactions.
Jack A. Taylor and Allen J. Wilcox of
the NIEHS Epidemiology Branch are
working with the EPA and NCHS to
assemble a bank of DNA specimens with
linked environmental exposure and health
outcomes from 11,000 persons who repre-
sent a random sample of the U.S. popula-
tion. Subsamples from this collection will
be used to establish precise gene frequen-
cies for the entire U.S. population, as well
as for ethnic and regional subpopulations.
This information will be crucial for risk
assessment and genetic screening.
Taylor and Douglas A. Bell of the
NIEHS Laboratory of Biochemical Risk
Analysis are developing both laboratory
techniques and methods for large-scale
population studies of susceptibility. The
strategy of identifying susceptibility genes
and then testing them in epidemiologic
studies will produce powerful tools for
detecting environmental hazards. On a
broader scale, this program will help lay
the groundwork for a new era of health
research that more fully integrates genetic
and environmental factors as causes of
human disease.
Human Melanoma Gene
Mapped by NIEHS/University
of Utah
Roger W. Wiseman and Monica E. Hegi
of the NIEHS Laboratory of Molecular
Carcinogenesis and Lisa Cannon-Albright
and Mark Skolnick at the University of
Utah have collected extensive pedigrees of
melanoma-susceptible families and have
performed genetic linkage analyses. Col-
laborating with the Utah group, NIEHS
intramural scientists have analyzed the
DNA of melanoma tissues from affected
family members. Using this information,
the melanoma susceptibility gene was
mapped to a small region on the short arm
of chromosome 9. This work was pub-
lished in Science and has received attention
in the lay press.
The work provides a means ofidentify-
ing and monitoring high-risk individuals
and counseling them about what they can
do to reduce the likelihood of developing
melanoma. This research may enable scien-
tists to understand the normal biological
function of the melanoma susceptibility
gene and to develop therapeutic strategies
to reduce an individual's risk ofdeveloping
melanoma even in the face ofgenetic factors.
Molecular Genetics of
Diethylstilbestrol-associated
Tumors
Jeffrey A. Boyd and colleagues in the
NIEHS Laboratory ofMolecular Carcino-
genesis have begun to search for potential
genetic markers in diethylstilbestrol-associ-
ated human tumors. In collaboration with
the Department of Gynecology at the
University of Texas M.D. Anderson
Cancer Center in Houston, a panel offor-
malin-fixed, paraffin-embedded vaginal
clear-cell adenocarcinomas was collected
from pathology archives. DNA was ex-
tracted from these samples and is currently
being subjected to molecular genetic analysis.
Using recently developed procedures based
on the polymerase chain reaction (PCR), it
will be possible to examine the DNA sam-
ples for mutations in candidate genes, such
as ras and p53. Boyd and co-workers plan
to conduct allelic deletion analysis for loci
throughout the human genome to identify
potential supressor genes that may be
involved in vaginal clear-cell adenocarcino-
mas. A concomitant analysis of DES-
induced mouse reproductive tract tumors
from the pathology archives at NIEHS will
contribute to this effort.
NIEHS was a co-sponsor of the April
1992 "NIH Workshop on Long-Term
Effects of Exposure to DES," with the
National Cancer Institute, the National
Institute of Child Health and Human
Development, and the NIH Office on
Research on Women's Health. This work-
shop brought together scientists, policy
makers, and groups representing DES-
exposed persons for an update and assess-
ment of future research needs. Since the
workshop, groups such as the DES Cancer
Network and DES Action USA have met
at NIH for several joint meetings with
NIEHS, NCI, NICHD, and ORWH to
receive updates on program initiatives and
research progress.
In January 1993, NIEHS participated
with the NIH in progress reports to
Congresswoman Louise Slaughter (D-New
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York), who introduced "DES Education
and Research Amendments of 1992" (H.R.
4178); the companion bill was S.2837,
introduced by Senator Tom Harkin (D-
Iowa).
Role of p53 in Cellular
Response to DNA Damage
Normally, when DNA is damaged, synthe-
sis ofnew DNA is halted until the DNA is
repaired. If synthesis is not halted, newly
synthesized DNA may be at risk for genet-
ic errors, which could lead to malignancies.
Michael Kastan, an NIEHS grantee at
Johns Hopkins University, has investigated
the role of p53 in the cellular response to
DNA damage. Elucidation of p53 gene
expression is particularly important be-
cause it is the most commonly mutated
gene in human cancer.
Kastan's laboratory has demonstrated,
confirmed, and clarified the link between
p53 and the arrest of the cell cycle at the
GI phase after ionizing radiation. His lab-
oratory has observed this phenomenon in
many cell types and in several tumor cell
lines. Kastan and colleagues transfected a
cell line (HL-60) that had no endogenous
p53 with wild-type p53. These transfected
cells demonstrated GI arrest after irradia-
tion. A tumor cell line was transfected
with a mutant p53 gene and did not dem-
onstrateGI arrest after irradiation.
Normal fibroblasts from mice in which
both alleles of p53 had been disrupted
were defective at this GI checkpoint.
Kastan's laboratory is now investigating
agents that affect p53 levels. Topoisom-
erase inhibitors induce p53, whereas base-
damaging agents do not. Kastan is also
studying the biochemical pathways
involved in altering p53 protein levels and
cell-cycle progression after DNA damage.
His group has demonstrated that genes
that are defective in the cancer-prone dis-
ease ataxia-telangiectasia are necessary for
the induction ofthe p53 protein. Finally,
they have shown that the gene GADD45,
which is activated by growth arrest or
DNA damage, is regulated by p53.
Air Pollutant Related to
Genetic Damage in Poland
Frederica Perera and colleagues at Colum-
bia University, Sweden's Center for Nu-
trition and Toxicology, and the Institute of
Oncology in Poland have provided the
clearest evidence to date of a direct link
between environmental air pollutants and
cancer-related genetic damage. This study,
published in Nature and funded in part by
NIEHS, broke new ground by using a
sophisticated battery of biomarkers to
detect potential environmental cancer risk.
The researchers studied two population
groups in Poland, a highly exposed group
living in the town of Gliwice, Upper
Silesia, characterized by high rates of can-
cer, and unexposed controls from Biala
Podlaska, a rural province with roughly
one-tenth the air pollution levels in
Gliwice.
Perera and her colleagues found con-
siderably higher levels of DNA and chro-
mosomal damage in the exposed popula-
tion compared to the controls. A doubling
in the frequency of oncogene activation
also occurred in the exposed group. These
studies provide a molecular link between
the environmental exposure and a genetic
alteration relevant to cancer and reproduc-
tive risk.
Protein Identified that
Protects against Lymphomas
Transgenic mice that express the human
homolog ofa particular protein in the thy-
mus were protected when exposed to a
known carcinogen, N-methyl-N-nitro-
sourea, in a study conducted under an
NIEHS grant by Stanton Gerson at Case
Western Reserve University. Findings of
the study were published in Science in
January 1993. In view of these findings
with experimental tumors, gene therapy
methods may merit consideration.
NIEHS Laboratory of
Molecular Genetics Receives
Award
Michael Resnick's laboratory within the
NIEHS Laboratory of Molecular Genetics
has received a $470,000 award from the
National Center for Human Genome
Research, NIH, to
continue studies on
the role of recombi-
nation in the insta-
bility of human
DNA containing
yeast artificial chro-
mosomes (YACs)
with the purpose of
developing a system
that has few errors. Dr. Michael Resnick
The Human Genome Initiative is a
worldwide effort to map and sequence the
human genome as well as to identify and
characterize sources of genetic disease.
These efforts rely heavily on the use of
YACs; however, as many as 50% ofYACs
containing human DNA have deletions,
rearrangements, or noncontiguous chro-
mosomal sequences.
Resnick's laboratory, in collaboration
with Vladimer Larionov and Natasha
Kouprina, visiting scientists from St.
Petersburg, Russia, has been able to dem-
onstrate that recombination is a key source
of errors in cloning and maintaining
human DNAs in yeast. The laboratory's
work, previously supported by the De-
partment ofEnergy, has led to the identifi-
cation ofmechanisms and genetic controls
of the errors and has already elucidated
some of the underlying mechanisms of
recombination in eukaryotes.
Tumor-Suppressor Genes and
Oncogenes
The NIEHS Laboratory of Molecular
Carcinogenesis uses microcell-mediated
chromosome transfer techniques to locate
chromosomes containing a variety of hu-
man and rodent cancer tumor-suppressor
genes. In collaboration with John Isaacs of
Johns Hopkins University, the laboratory,
directed by J. Carl Barrett, has shown that
somatic cell hybridization of highly
metastatic and nonmetastatic rat prostate
cancer cells can be rendered nonmetastatic.
Because the major problems associated
with prostate cancer morbidity and mortal-
ity are a consequence of its ability to ag-
gressively spread to the bone, attempts are
being made to locate the region of the
human chromosome that confers metastat-
ic ability to cancerous prostate cells. The
gene has been shown to lie in a specific
region (between IIp11.2-13, but not
including the Wilms' tumor-I locus). Fur-
ther attempts at characterization are ongo-
ing.
NIEHS Joins EPA and NCI in
Agricultural Health Study
NIEHS has joined the Environmental
Protection Agency and the National
Cancer Institute in a $15-million, 10-year
epidemiological study on the health of
farmers, their families, and other workers
who apply agricultural chemicals. Al-
though the study will look closely at can-
cers, NIEHS will especially look at non-
cancer disease and dysfunction, including
reproductive effects, childhood and adult
asthma, immunological effects, lactation,
neurological outcomes, childhood develop-
ment, kidney disease, and birth defects.
Dale P. Sandler, NIEHS Epidemiology
Branch, will lead the study at NIEHS.
Subjects for the study will be selected
from farm families and agricultural work-
ers in Iowa and North Carolina. The sub-
jects in the Iowa cohort will be primarily
white, but the North Carolina cohort will
include a substantial number ofnonwhites,
especially African-Americans and Native
Americans. The 200 households in the
study will be monitored at least twice, dur-
ing the growing season and off-season, and
the study will evaluate environmental fac-
tors (air, water, food, soil, house dust) as
well as biological samples (blood and
urine).
Kenneth Olden, NIEHS director, has
visited Iowa farm families to discuss envi-
ronmental health concerns with those
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